Evidence map›Paper›PMID 41642980›Full record

ArticleJournal of cataract and refractive surgery2026

Failure of endophthalmitis prophylaxis: laboratory model comparing antibiotics and bacterial loads.

Max Moon, Sean Mathews, Faria Mahjabin, Katerina Karaiskos, Peter E Libre

Abstract readComparative Study
In one paragraph

Article in Journal of cataract and refractive surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Max MoonFrom the Tulane University School of Medicine, New Orleans, Louisiana (Moon); Saint George's University School of Medicine, St. George's, Grenada (Mathews); Frank H. Netter School of Medicine at Quinnipiac University, North Haven, Connecticut (Mahjabin); Yale School of Public Health, New Haven, Connecticut (Karaiskos); Columbia University Irving Medical Center, New York, New York (Libre).
Sean Mathews
Faria Mahjabin
Katerina Karaiskos
Peter E Libre

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeTo assess by an in vitro model the influence of antibiotic agent and bacterial load on the failure of intracameral endophthalmitis prophylaxis.

settingMicrobiology laboratory.

designBacterial growth comparison.

methodsBacteria were incubated with moxifloxacin, cefuroxime, ceftazidime, or imipenem. Antibiotic concentrations were approximately twice those achieved by standard clinical intracameral doses. Bacterial loads were either low or high (0.0025 or 0.25 McFarland). The tested strains included 4 Enterococcus faecium , 7 Klebsiella pneumoniae , 8 methicillin-resistant Staphylococcus aureus , 3 Streptococcus pneumoniae , and 6 Pseudomonas aeruginosa . Samples were diluted by half every 2 hours to model the half-life of intracameral antibiotics. Bacterial broths were plated at 24 hours, and colonies were counted at 48 hours. Samples with >250 colony forming units /mL were deemed failures.

resultsAntibiotics that successfully eliminated a pathogen often failed when the bacterial load was 100 times greater. Moxifloxacin had no failures against low-load pathogens. Moxifloxacin and ceftazidime both had significantly fewer failures than cefuroxime ( P < .01; P > .02). Ceftazidime was far more effective than cefuroxime against gram negatives, but less effective against low-load enterococci.

conclusionsHigh bacterial loads can multiply uncontrollably in the presence of antibiotics which are effective when the bacterial load is lower; this underscores the importance of uncontaminated equipment and ocular surface antisepsis. Broadest coverage against common postoperative endophthalmitis pathogens was demonstrated by moxifloxacin and ceftazidime.

Indexed as

Anti-Bacterial AgentsAntibiotic ProphylaxisBacteriaBacterial LoadEndophthalmitisEye Infections, BacterialAza CompoundsCeftazidimeCefuroximeColony Count, MicrobialEnterococcus faeciumFluoroquinolonesHumansImipenemIntracameral InjectionKlebsiella pneumoniaeAnti-Bacterial AgentsAza CompoundsCeftazidimeCefuroximeFluoroquinolonesImipenemMoxifloxacinQuinolinesSecond Generation Cephalosporins

Identifiers

PMID41642980
PMCPMC13200904

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.